VYNE Therapeutics (VYNE) EBT (QoQ) (2017 - 2025)
VYNE Therapeutics (VYNE) EBT (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,792.52 Bn | 1,792.46 Bn | - |
| 2 | Akari Therapeutics | 999.95 Bn | 999.95 Bn | - |
| 3 | BeOne Medicines | 475.97 Bn | 471.17 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 124.91 Bn | 117.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 72.31 Bn | 63.56 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.01 Bn | 62.01 Bn | - |
| 7 | Argenx Se | 54.23 Bn | 49.04 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.31 Bn | 35.30 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.16 Bn | 36.16 Bn | - |
| 10 | VYNE Therapeutics | 1.22 Bn | 1.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 33.20% |
| Mar 31, 2025 | 28.37% |
| Dec 31, 2024 | 1.21% |
| Sep 30, 2024 | -29.40% |
| Jun 30, 2024 | -50.54% |
| Mar 31, 2024 | -1.45% |
| Dec 31, 2023 | -1.33% |
| Sep 30, 2023 | 39.52% |
| Jun 30, 2023 | -78.87% |
| Mar 31, 2023 | 27.57% |
| Dec 31, 2022 | 16.28% |
| Sep 30, 2022 | -12.39% |
| Jun 30, 2022 | 5.28% |
| Mar 31, 2022 | 1.43% |
| Dec 31, 2021 | 38.22% |
| Sep 30, 2021 | -33.61% |
| Jun 30, 2021 | 1.76% |
| Mar 31, 2021 | 53.08% |
| Dec 31, 2020 | 6.20% |
| Sep 30, 2020 | 85.26% |